DED pain origins are important to consider when determining treatment strategies for individuals with the disorder.

AlgoTherapeutix (AlgoTx), a clinical stage biotechnology company developing a first-in-class therapeutic for peripheral neuropathic pain, ATX01, announced today the completion of the Last Patient Last ...

At NexGenEsis in Houston, Texas, doctors help their patients find relief from pain by turning on the body's healing power ...

Dimethyl sulfoxide (DMSO) is a compound used in many products, such as makeup, paint removers, cleaners, essential oils, and ...

These drugs can help by either blocking pain signals or changing how the brain processes pain. Topical Creams ... supplements ...

As for any painful diagnosis, treatment options are imperfect ... less invasive procedures for interrupting the pain of TN by inducing a partial nerve injury. Partial or permanent facial numbness ...

Thus, many treatments ... stabbing or electrical, facial pain syndrome. The likely etiology in many cases is vascular compression of the trigeminal nerve root entry zone, leading to focal ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing innovative therapies for neurologic and neuropsychiatric disorders, announced today that it ...

Current treatment options for neuropathic pain, including antidepressants, anticonvulsants, topical agents, and opioids, often provide limited relief and include significant side effects.